Multiple Endocrine Neoplasia 1 Gene Alterations in MEN1-Associated and Sporadic Lipomas
Authors:
- Alexander O. VortmeyerAVAlexander O. Vortmeyer
- Evgenia PakEPEvgenia Pak
- Svetlana PackSPSvetlana Pack
- Roland BöniRBRoland Böni
- Zhengping ZhuangZZZhengping Zhuang
Open Access
- 4 March 1998
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 90 (5) , 398-399
Abstract
Multiple endocrine neoplasia 1 (MEN1) syndrome is characterized by the development of parathyroid adenomas, pituitary adenomas, and duodenal and/or pancreatic neuroendocrine tumors. The vast majority, and possibly all, of these tumors are characterized by two genetic hits—germline mutation of the MEN1 tumor suppressor gene combined with allelic deletion of the corresponding wild-type allele (1). Alterations of the MEN1 gene are not only found in MEN1-associated tumors but also, with decreasing frequency, in sporadic neuroendocrine tumors of the foregut (2,3), parathyroid tumors (4), and pituitary adenomas (5).Keywords
This publication has 5 references indexed in Scilit:
- Mutations in the MEN I gene in sporadic neuroendocrine tumours of gastroenteropancreatic systemThe Lancet, 1997
- Somatic mutation of the MEN1 gene in parathyroid tumoursNature Genetics, 1997
- A 2.8-Mb Clone Contig of the Multiple Endocrine Neoplasia Type 1 (MEN1) Region at 11q13Genomics, 1997
- Loss of Heterozygosity at 11q13: Analysis of Pituitary Tumors, Lung Carcinoids, Lipomas, and Other Uncommon Tumors in Subjects with Familial Multiple Endocrine Neoplasia Type 1The Journal of Clinical Endocrinology & Metabolism, 1997
- Positional Cloning of the Gene for Multiple Endocrine Neoplasia-Type 1Science, 1997